Related Experiment Video
Updated: Jun 17, 2026

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
Published on: February 23, 2019
Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human
1Department of Dermatology, Changhai Hospital, Second Military Medical University, Shanghai, PR China.
Background:
Arsenic is a carcinogen that is associated with an increased risk of human skin cancer. On the other hand, arsenic trioxide (As(2)O(3)) has potential anticancer activity against a wide range of carcinomas. The mechanisms involved in these two opposing processes remain unclear.
Methods:
We used normal human keratinocytes (NHK), the human keratinocyte HaCaT cell line and human epidermal carcinoma cells (A431 cell line) to investigate potential pathways involved in the effects on cell proliferation and growth inhibition by different concentrations of As(2)O(3).
Results:
At low concentrations (0.5-32 nM), As(2)O(3) enhanced keratinocyte proliferation and regulated the expression of about 172 genes. Among them, cell cycling pathway genes (including CDK4 and E2F1) were significantly upregulated. At high concentrations (0.5-10 microM), As(2)O(3) inhibited cell growth in NHK and HaCaT cells, but not in A431 cells. As(2)O(3) significantly induced NHK and HaCaT apoptosis through the activation of caspase-3, as well as cell cycle arrest at the G2-M phase.
Conclusion:
Our data suggest that different pathways are involved in As(2)O(3)-mediated proliferation and growth inhibition. In addition, skin carcinoma cells were resistant to As(2)O(3)-induced cell growth inhibition and apoptosis when compared to NHK and HaCaT cells. Therefore, As(2)O(3) may not be appropriate for treatment of skin carcinomas.
Insights
Arsenic trioxide (As(2)O(3)) shows dual effects: low doses promote keratinocyte proliferation, while high doses induce apoptosis and cell cycle arrest. Skin carcinoma cells, however, are resistant to As(2)O(3) growth inhibition.
Area of Science:
- Toxicology
- Molecular Biology
- Dermatology
Background:
- Arsenic is a known carcinogen linked to skin cancer.
- Arsenic trioxide (As(2)O(3)) exhibits potential anticancer properties.
- The mechanisms behind arsenic's opposing effects on skin cells are not fully understood.
Purpose of the Study:
- To investigate the effects of As(2)O(3) on keratinocyte proliferation and growth inhibition.
- To explore the molecular pathways influenced by As(2)O(3) in normal and cancerous skin cells.
Main Methods:
- Utilized normal human keratinocytes (NHK), HaCaT cells, and A431 epidermal carcinoma cells.
- Exposed cells to varying concentrations of As(2)O(3) (0.5-32 nM and 0.5-10 microM).
- Assessed cell proliferation, gene expression, apoptosis (caspase-3 activation), and cell cycle progression (G2-M arrest).
Main Results:
- Low As(2)O(3) concentrations (0.5-32 nM) enhanced keratinocyte proliferation and upregulated cell cycling genes (e.g., CDK4, E2F1).
- High As(2)O(3) concentrations (0.5-10 microM) inhibited NHK and HaCaT cell growth, induced apoptosis via caspase-3, and caused G2-M cell cycle arrest.
- A431 skin carcinoma cells demonstrated resistance to As(2)O(3)-induced growth inhibition and apoptosis.
Conclusions:
- As(2)O(3) exerts differential effects on skin cells, promoting proliferation at low doses and inducing cell death at high doses.
- Skin carcinoma cells exhibit resistance to the cytotoxic effects of As(2)O(3).
- As(2)O(3) may not be a suitable therapeutic agent for treating skin carcinomas due to observed resistance.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mutagenicity and Carcinogenicity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

